WhitTier Trust Company’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.13K Buy
149
+48
+48% +$1.2K ﹤0.01% 1244
2026
Q1
$2.4K Buy
101
+87
+621% +$2.45K ﹤0.01% 1254
2025
Q4
$486 Hold
14
﹤0.01% 1241
2025
Q3
$504 Hold
14
﹤0.01% 1239
2025
Q2
$806 Hold
14
﹤0.01% 1371
2025
Q1
$815 Hold
14
﹤0.01% 1350
2024
Q4
$1.13K Buy
+14
New +$1.2K ﹤0.01% 1271

Other funds holding PRCT

WhitTier Trust Company's PRCT Position: Q2 2026 in Review

WhitTier Trust Company increased its Procept Biorobotics (PRCT) stake by 48% in Q2 2026, buying an estimated $1.2K and bringing the position to 149 shares worth $3.13K. The position accounts for ﹤0.01% of the portfolio, ranked #1244.

WhitTier Trust Company first reported a position in PRCT in Q4 2024 and has held it in 7 quarters since. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • WhitTier Trust Company held 149 shares of Procept Biorobotics worth $3.13K as of Q2 2026.
  • WhitTier Trust Company bought 48 Procept Biorobotics shares in Q2 2026, an estimated $1.2K.
  • Procept Biorobotics made up ﹤0.01% of WhitTier Trust Company's portfolio in Q2 2026, its #1244 holding.
  • WhitTier Trust Company first reported a position in Procept Biorobotics in Q4 2024 and has held it in 7 quarters since.
  • 253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on WhitTier Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.